In humans, gain-of-function mutations in TMEM173, the gene that encodes for STING, result in STING-associated vasculopathy with onset in infancy (SAVI), an inflammatory disease characterized by upregulated expression of genes associated with the type I IFN (IFNI) pathway (11). This evidence concerns the gene STING1 and vascular disorder.